158 related articles for article (PubMed ID: 9421104)
1. Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting.
Gorodischer R; Burtin P; Verjee Z; Hwang P; Koren G
Ther Drug Monit; 1997 Dec; 19(6):637-42. PubMed ID: 9421104
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
Vasudev A; Tripathi KD; Puri V
Neurol India; 2002 Mar; 50(1):60-2. PubMed ID: 11960153
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of antiepileptic drugs by use of saliva.
Patsalos PN; Berry DJ
Ther Drug Monit; 2013 Feb; 35(1):4-29. PubMed ID: 23288091
[TBL] [Abstract][Full Text] [Related]
4. [Saliva and plasma levels of carbamazepine have a poor correlation: a pilot study].
Mennickent S; Vega M; Godoy CG; León MD
Rev Med Chil; 2007 Mar; 135(3):335-40. PubMed ID: 17505579
[TBL] [Abstract][Full Text] [Related]
5. Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
Li RR; Sheng XY; Ma LY; Yao HX; Cai LX; Chen CY; Zhu SN; Zhou Y; Wu Y; Cui YM
Ther Drug Monit; 2016 Jun; 38(3):365-70. PubMed ID: 26818624
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
Miles MV; Tang PH; Ryan MA; Grim SA; Fakhoury TA; Strawsburg RH; DeGrauw TJ; Baumann RJ
Ther Drug Monit; 2004 Jun; 26(3):300-4. PubMed ID: 15167632
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of saliva for perampanel therapeutic drug monitoring.
Kim DY; Moon J; Shin YW; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee S; Yu KS; Jang IJ; Song K; Chu K; Lee S
Epilepsia; 2020 Jun; 61(6):1120-1128. PubMed ID: 32378757
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and acceptance of salivary monitoring of antiepileptic drugs via the US Postal Service.
Tennison M; Ali I; Miles MV; D'Cruz O; Vaughn B; Greenwood R
Ther Drug Monit; 2004 Jun; 26(3):295-9. PubMed ID: 15167631
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of concentrations of clobazam and norclobazam in serum and saliva of children with epilepsy.
Bardy AH; Seppälä T; Salokorpi T; Granström ML; Santavuori P
Brain Dev; 1991 May; 13(3):174-9. PubMed ID: 1928610
[TBL] [Abstract][Full Text] [Related]
10. Interactions of clobazam with conventional antiepileptics in children.
Theis JG; Koren G; Daneman R; Sherwin AL; Menzano E; Cortez M; Hwang P
J Child Neurol; 1997 Apr; 12(3):208-13. PubMed ID: 9130097
[TBL] [Abstract][Full Text] [Related]
11. Comparison of plasma, saliva, and hair lamotrigine concentrations.
Kuczynska J; Karas-Ruszczyk K; Zakrzewska A; Dermanowski M; Sienkiewicz-Jarosz H; Kurkowska-Jastrzebska I; Bienkowski P; Konopko M; Dominiak M; Mierzejewski P
Clin Biochem; 2019 Dec; 74():24-30. PubMed ID: 31672648
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications.
Shaikh AS; Guo R
Curr Pharm Biotechnol; 2017; 18(13):1098-1105. PubMed ID: 29437004
[TBL] [Abstract][Full Text] [Related]
13. Correlation of lamotrigine concentrations between serum and saliva.
Ryan M; Grim SA; Miles MV; Tang PH; Fakhoury TA; Strawsburg RH; deGrauw TJ; Baumann RJ
Pharmacotherapy; 2003 Dec; 23(12):1550-7. PubMed ID: 14695035
[TBL] [Abstract][Full Text] [Related]
14. Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy.
Franco V; Gatti G; Mazzucchelli I; Marchiselli R; Fattore C; Rota P; Galimberti CA; Capovilla G; Beccaria F; De Giorgis V; Johannessen Landmark C; Perucca E
Epilepsia; 2020 Jul; 61(7):e79-e84. PubMed ID: 32562438
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants.
Liu H; Delgado MR
Clin Pharmacokinet; 1999 Jun; 36(6):453-70. PubMed ID: 10427469
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring therapy by analysis of the drug concentration of saliva].
Bartels H; Günther E; Wallis S
Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
[TBL] [Abstract][Full Text] [Related]
17. Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy.
Dwivedi R; Gupta YK; Singh M; Joshi R; Tiwari P; Kaleekal T; Tripathi M
Seizure; 2015 Feb; 25():187-90. PubMed ID: 25455060
[TBL] [Abstract][Full Text] [Related]
18. An audit of therapeutic drug monitoring of anticonvulsants.
Sharpe PC; Morrow J; Trimble ER
Ulster Med J; 1995 Oct; 64(2):151-6. PubMed ID: 8533181
[TBL] [Abstract][Full Text] [Related]
19. Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva.
Dwivedi R; Singh M; Kaleekal T; Gupta YK; Tripathi M
Int J Neurosci; 2016 Nov; 126(11):972-8. PubMed ID: 26441313
[TBL] [Abstract][Full Text] [Related]
20. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth.
Kamali F; McLaughlin WS; Ball DE; Seymour RA
J Clin Periodontol; 1999 Dec; 26(12):802-5. PubMed ID: 10599907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
